(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

NOGRAPHARMA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

NOGRAPHARMA

ST13

US500000090272165

Class

5

Filing

90272165

Registration

6403434

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

20

Latest update

06/29/2026

Trademark type

Combined

Nice classes

5

Filing date

10/22/2020

Registration date

06/29/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/29/2021

Last transaction

06/29/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

3

Owner type

77

Owner location

Dublin 2, IE

Examiner

REINHART, MEGHAN M

Law office

L80

Current location

PETITIONS OFFICE

Mark description

The mark consists of the words "NOGRAPHARMA" without a space between the two words, with a design of two ovals to the left of the words.

Holders and representatives

Holders

Nogra Pharma Limited

Representatives

Michael A. Marrero ULMER & BERNE LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

pharmaceutical preparations for the treatment of immune-system-related diseases and disorders and inflammatory disordersgastrointestinal diseases and disorders and skin disorders

Publications

History of USPTO decisions and trademark events.

20 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

06/29/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

06/29/2021

CHPB

POST PUBLICATION AMENDMENT - ENTERED

05/15/2021

APET

ASSIGNED TO PETITION STAFF

05/15/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/13/2021

PUBO

PUBLISHED FOR OPPOSITION

04/13/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/24/2021

FIXD

ELECTRONIC RECORD REVIEW COMPLETE

03/10/2021

ERRR

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

03/05/2021

EPPA

TEAS POST PUBLICATION AMENDMENT RECEIVED

03/01/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/01/2021

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

02/27/2021

GNRT

NON-FINAL ACTION E-MAILED

02/27/2021

CNRT

NON-FINAL ACTION WRITTEN

02/27/2021

DOCK

ASSIGNED TO EXAMINER

02/20/2021

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

12/11/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/10/2020

TAEA

TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED

10/27/2020

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

10/27/2020

NWAP

NEW APPLICATION ENTERED

10/26/2020

Continuous trademark protection

Get notified about every new filing that threatens NOGRAPHARMA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.